Renal Organic Anion Transporters (SLC22 Family): Expression, Regulation, Roles in Toxicity, and Impact on Injury and Disease

被引:213
作者
Wang, Li [1 ]
Sweet, Douglas H. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA 23298 USA
关键词
kidney; nephrotoxicity; proximal tubule; solute carrier; ARISTOLOCHIC ACID NEPHROPATHY; TISSUE-SPECIFIC EXPRESSION; DRUG-DRUG INTERACTION; DOWN-REGULATION; URIC-ACID; NITRIC-OXIDE; IN-VITRO; OAT1; KIDNEY; GENE;
D O I
10.1208/s12248-012-9413-y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Organic solute flux across the basolateral and apical membranes of renal proximal tubule cells is a key process for maintaining systemic homeostasis. It represents an important route for the elimination of metabolic waste products and xenobiotics, as well as for the reclamation of essential compounds. Members of the organic anion transporter (OAT, SLC22) family expressed in proximal tubules comprise one pathway mediating the active renal secretion and reabsorption of organic anions. Many drugs, pesticides, hormones, heavy metal conjugates, components of phytomedicines, and toxins are OAT substrates. Thus, through transporter activity, the kidney can be a target organ for their beneficial or detrimental effects. Detailed knowledge of the OATs expressed in the kidney, their membrane targeting, substrate specificity, and mechanisms of action is essential to understanding organ function and dysfunction. The intracellular processes controlling OAT expression and function, and that can thus modulate kidney transport capacity, are also critical to this understanding. Such knowledge is also providing insight to new areas such as renal transplant research. This review will provide an overview of the OATs for which transport activity has been demonstrated and expression/function in the kidney observed. Examples establishing a role for renal OATs in drug clearance, food/drug-drug interactions, and renal injury and pathology are presented. An update of the current information regarding the regulation of OAT expression is also provided.
引用
收藏
页码:53 / 69
页数:17
相关论文
共 108 条
[1]   Linkage of Organic Anion Transporter-1 to Metabolic Pathways through Integrated "Omics"-driven Network and Functional Analysis [J].
Ahn, Sun-Young ;
Jamshidi, Neema ;
Mo, Monica L. ;
Wu, Wei ;
Eraly, Satish A. ;
Dnyanmote, Ankur ;
Bush, Kevin T. ;
Gallegos, Tom F. ;
Sweet, Douglas H. ;
Palsson, Bernhard O. ;
Nigam, Sanjay K. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (36) :31522-31531
[2]   Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells [J].
Aslamkhan, AG ;
Han, YH ;
Yang, XP ;
Zalups, RK ;
Pritchard, JB .
MOLECULAR PHARMACOLOGY, 2003, 63 (03) :590-596
[3]   Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3) [J].
Astorga, Bethzaida ;
Wunz, Theresa M. ;
Morales, Mark ;
Wright, Stephen H. ;
Pelis, Ryan M. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (02) :F378-F386
[4]   Interactions of Human Organic Anion Transporters With Aristolochic Acids [J].
Babu, Ellappan ;
Takeda, Michio ;
Nishida, Ritsuo ;
Noshiro-Kofuji, Rie ;
Yoshida, Masaaki ;
Ueda, Shiro ;
Fukutomi, Toshiyuki ;
Anzai, Naohiko ;
Endou, Hitoshi .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 113 (02) :192-196
[5]   Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy [J].
Bakhiya, Nadiya ;
Arlt, Volker M. ;
Bahn, Andrew ;
Burckhardt, Gerhard ;
Phillips, David H. ;
Glatt, Hansruedi .
TOXICOLOGY, 2009, 264 (1-2) :74-79
[6]   Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport [J].
Barros, Scott A. ;
Srimaroeng, Chutima ;
Perry, Jennifer L. ;
Walden, Ramsey ;
Dembla-Rajpal, Neetu ;
Sweet, Douglas H. ;
Pritchard, John B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (05) :2672-2679
[7]   Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3) [J].
Bhatnagar, Vibha ;
Xu, Gang ;
Hamilton, Bruce A. ;
Truong, David M. ;
Eraly, Satish A. ;
Wu, Wei ;
Nigam, Sanjay K. .
JOURNAL OF HUMAN GENETICS, 2006, 51 (06) :575-580
[8]  
BOURKE RS, 1975, CANCER RES, V35, P110
[9]   Interactions of human organic anion transporter 1 (hOAT1) with substances associated with forensic toxicology [J].
Chiba, Shoetsu ;
Ikawa, Toru ;
Takeshita, Hiroshi ;
Ichiba, Kazue ;
Sagi, Morihisa ;
Mukai, Toshiji ;
Anzai, Naohiro .
LEGAL MEDICINE, 2011, 13 (04) :180-185
[10]   Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions [J].
Choi, Min-Koo ;
Jin, Qing-Ri ;
Choi, Yeong-Lim ;
Ahn, Sung-Hoon ;
Bae, Myung-Ae ;
Song, Im-Sook .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2011, 32 (03) :175-184